Bank Of America Corp Cerevel Therapeutics Holdings, Inc. Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

A detailed history of Bank Of America Corp transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 338,455 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
338,455
Previous 220,907 53.21%
Holding current value
$0
Previous $9.34 Million 48.22%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $4.58 Million - $5.03 Million
117,548 Added 53.21%
338,455 $13.8 Million
Q1 2024

May 15, 2024
BUY
$40.88 - $43.27 $6.08 Million - $6.43 Million
148,612 Added 205.56%
220,907 $9.34 Million
Q4 2023

Feb 14, 2024
SELL
$20.27 - $42.44 $1.38 Million - $2.9 Million
-68,255 Reduced 48.56%
72,295 $3.07 Million
Q2 2023

Aug 14, 2023
SELL
$23.9 - $35.38 $3.22 Million - $4.77 Million
-134,826 Reduced 48.96%
140,550 $4.47 Million
Q1 2023

May 12, 2023
BUY
$22.82 - $35.32 $1.16 Million - $1.79 Million
50,804 Added 22.62%
275,376 $6.72 Million
Q4 2022

Feb 10, 2023
BUY
$25.35 - $31.96 $2.84 Million - $3.59 Million
112,212 Added 99.87%
224,572 $7.08 Million
Q3 2022

Nov 14, 2022
BUY
$25.5 - $41.42 $2.29 Million - $3.73 Million
89,963 Added 401.67%
112,360 $3.18 Million
Q2 2022

Aug 12, 2022
SELL
$20.62 - $37.15 $923,631 - $1.66 Million
-44,793 Reduced 66.67%
22,397 $592,000
Q1 2022

May 16, 2022
SELL
$23.5 - $35.38 $230,958 - $347,714
-9,828 Reduced 12.76%
67,190 $2.35 Million
Q4 2021

Feb 08, 2022
BUY
$29.21 - $44.64 $1.21 Million - $1.85 Million
41,363 Added 116.01%
77,018 $2.5 Million
Q3 2021

Nov 15, 2021
BUY
$21.26 - $38.85 $647,707 - $1.18 Million
30,466 Added 587.13%
35,655 $1.05 Million
Q2 2021

Sep 13, 2021
BUY
$12.56 - $29.69 $65,173 - $154,061
5,189 New
5,189 $133,000

Others Institutions Holding CERE

# of Institutions
227
Shares Held
153M
Call Options Held
2.19M
Put Options Held
3.84M
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email